Transcarent Revenue and Competitors

Location

#731

Growjo Ranking

Estimated Revenue & Valuation

  • Transcarent's estimated annual revenue is currently $66.1M per year.(i)
  • Transcarent's estimated revenue per employee is $177,800
  • Transcarent's current valuation is $1.6B. (January 2022)

Employee Data

  • Transcarent has 372 Employees.(i)
  • Transcarent grew their employee count by 18% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$203M1014-20%$65MN/A
#2
$33.4M2172%N/AN/A
#3
$45M299-4%$102.6MN/A
#4
$3.2M30-25%$21.3MN/A
#5
$34M2260%$42.9MN/A
#6
$3.6M34-28%$35MN/A
#7
$0.8M10N/AN/AN/A
#8
$12.6M90-9%N/AN/A
#9
$17.4M1240%$96.4MN/A
#10
$7.9M6518%$75.6MN/A
Add Company

Transcarent is a stealth-stage startup in digital health space. Coming soon!

keywords:N/A

N/A

Total Funding

372

Number of Employees

$66.1M

Revenue (est)

18%

Employee Growth %

$1.6B

Valuation

N/A

Accelerator

Transcarent News

2022-04-17 - Transcarent unveils latest bet with new cancer care program

Transcarent Oncology Care aims to offer an end-to-end solution to better ... chief operating officer at Transcarent, told Fierce Healthcare.

2022-04-13 - Why Glen Tullman is backing virtual diabetes clinic 9am.health

In addition to leading Transcarent, a platform used by employees of self-insured companies to more easily access care, Tullman previously...

2022-04-13 - Transcarent rolls out new oncology service for self-insured ...

Transcarent, a health tech company for self-insured employers, announced a new program focused on the cancer-care space.

2021-07-30 - Bipin Mistry, Chief Medical Officer at Transcarent, on VatorNews podcast

Transcarent offers a consumer-directed health and care experience for employees Vator · Interview with Bipin Mistry, Chief Medical Officer at Transcarent Steven Loeb and Bambi Francisco interview Bipin Mistry, Chief Medical Officer at Transcarent, a company that offers a consumer-directed heal ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$67.4M3723%N/A
#2
$61.4M372-26%$1.6M
#3
$67.4M37279%N/A
#4
$66.3M373-4%$19.2M
#5
$61.6M373-7%$161.3M